C-Reactive Protein (CRP) Test Market
report by size, share, application, and geography – global forecast to 2028 is
a professional and in-depth research on the world’s major regional C-Reactive
Protein (CRP) Test market conditions, segmentation, key manufacturers and
driving factors.
Global C–Reactive protein (CRP) test market is anticipated
to exhibit a rise in the CAGR during its forecast period. C–Reactive protein is
an immunoprotein, which is synthesized in the liver and it helps in activation
of all the complement systems. The C–Reactive protein test measures the levels
of C-Reactive protein in the body and has the capability to find out if the
person is suffering from heart attacks or strokes. Under average circumstances,
CRP is stated in very low levels, but it has the efficiency to increase 1,000
folds in the span of 24 hours of tissue damage or infection.
Request Sample Copy
of this Market Research @ https://www.millioninsights.com/industry-reports/c-reactive-protein-crp-test-market-study/request-sample
It has been witnessed that there is a surge in number of
incidences of inflammatory disorders such as cardiovascular disorders and
cancer infections. This sudden rise is influencing the growth of the C–Reactive
protein test market massively. Along with this, another factor that is playing
a major role and is growing the market is the prevalence of endometriosis in
women. Looking at this wide-ranging market, there is still a lack of public
awareness for CRP tests, which is one of the major restraining factor for the
market. But due to the favorable policies of the government and more of
investments in its R&D, this market is expected to grow rapidly in the near
future.
The C–Reactive protein test market is segmented on the basis
of assay type (immunoturbidimetric assay, ELISA, chemiluminescence
immunoassay), detection range (hs – CRP, conventional CRP, cCRP), disease area
(cardiovascular diseases, cancer, rheumatoid, arthritis, inflammatory bowel
diseases, endometriosis, lupus), end user (clinics, hospitals, laboratories,
assisted living healthcare facilities, home) and region (North America, Europe,
Asia Pacific, Latin America, Middle East and Africa).
Mentioning about the assay type segmentation, in which
immunoturbidimetric assay is the fastest growing segment, because of the
players who are highly investing in its R&D sector. In addition to this,
immunoturbidimetric tests are surging and are accepted for protein assays.
Considering the end user insights, clinics have been
accounted for the largest revenue share and is anticipated to maintain the same
in the forthcoming years. The reason for its rise is the healthcare
infrastructure, which acts as a support to this segment.
North America having the largest revenue share dominates the
C–Reactive protein test market. Prominent players, technological advancements,
and well-structured infrastructures are the factors, accountable for the
dominance of this segment. Followed by this region, Asia Pacific is predicted
to arise as the fastest growing segment.
Some of the prominent key players of the C–Reactive protein
test market are Thermo Fisher Scientific, Inc., HORIBA Ltd., Randox
Laboratories Ltd., Abbott, Siemens Healthineers, F Hoffmann-La Roche Ltd.,
Quest Diagnostics, Getein Biotech, Inc., Ortho Clinical Diagnostics, Orion
Diagnostica Oy, Laboratory Corporation of America Holdings, BODITECH MED, INC.,
Danaher; Merck & Co., Inc., and Abaxis, Inc. All the leading companies are
including mergers and acquisitions, partnerships and joint ventures to enhance
the growth of the market efficiently.
Browse Complete
Report with TOC @ https://www.millioninsights.com/industry-reports/c-reactive-protein-crp-test-market-study
Market split by Type,
can be divided into:
• ELISA
• Immunoturbidimetric
• CLIA
• Others
Market split by
Application, can be divided into:
• Hospitals
• Diagnostic Laboratories
• Others
Market split by Sales
Channel, can be divided into:
• Direct Channel
• Distribution Channel
For More Information,
Visit Our Blog @ www.digitalmarket360.wordpress.com
